During the past decade, San Marcus Research Clinic, Inc. conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 46 clinical trials were completed, i.e. on average, 68.7% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 30 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Marcus Research Clinic, Inc." #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Pfizer" with 6 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored, "Incyte Corporation" with 5 trials sponsored and "Enanta Pharmaceuticals, Inc" with 5 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Marcus Research Clinic, Inc." #1 collaborator was "Novum Pharmaceutical Research Services" with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator and "Parexel" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "San Marcus Research Clinic, Inc." are "Rheumatoid Arthritis" (8 trials), "Arthritis, Rheumatoid" (5 trials), "Chronic Kidney Disease" (4 trials), "Atopic Dermatitis" (3 trials) and "Psoriatic Arthritis" (3 trials). Many other conditions were trialed in "San Marcus Research Clinic, Inc." in a lesser frequency.

Most popular intervention types in "San Marcus Research Clinic, Inc." are "Drug" (76 trials), "Biological" (7 trials), "Other" (6 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "Ruxolitinib cream" (4 trials), "Filgotinib" (3 trials), "Placebo to match filgotinib" (3 trials) and "Vehicle" (3 trials). Other intervention names were less common.

The vast majority of trials in "San Marcus Research Clinic, Inc." are 83 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "San Marcus Research Clinic, Inc.". undefined are not yet recruiting, 14 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in San Marcus Research Clinic, Inc., undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in San Marcus Research Clinic, Inc., 6 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".